Profil
Manfred G.
Ismair worked as a Chief Scientific Officer at XenoGesis Ltd.
and as a Senior Research Scientist at AstraZeneca R&D Charnwood.
Prior to that, he worked as a Scientist at UniversitätsSpital Zürich.
Ismair received his undergraduate degree from the University of Regensburg in 1993.
Anciens postes connus de Manfred G. Ismair
| Sociétés | Poste | Fin |
|---|---|---|
| AstraZeneca R&D Charnwood | Directeur Technique/Scientifique/R&D | - |
UniversitätsSpital Zürich
 UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services UniversitätsSpital Zürich is a renowned university hospital that specializes in university medicine, nursing, research, and teaching. UniversitätsSpital Zürich is based in Zurich, Switzerland. With over 42,000 inpatients and 600,000 outpatient consultations annually, the hospital has gained the trust of many patients. The hospital has approximately 8,500 employees and collaborates with over 40 clinics and institutes, providing patients with the expertise of its specialists and modern therapies. Gregor Zünd has been the CEO of the Swiss company since 1989. | Directeur Technique/Scientifique/R&D | - |
XenoGesis Ltd.
 XenoGesis Ltd. Medical/Nursing ServicesHealth Services XenoGesis Ltd. provides laboratory-based services to pharmaceutical clients. Its services include in vitro DMPK and pharmacology. PK, bioanalysis and metabolite identification, modelling and simulation, ADME packages, due diligence, and formulation service. The company was founded by Richard Weaver in 2011 and is headquartered in Nottingham, the United Kingdom. | Directeur Technique/Scientifique/R&D | - |
Formation de Manfred G. Ismair
| University of Regensburg | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
XenoGesis Ltd.
XenoGesis Ltd. Medical/Nursing ServicesHealth Services XenoGesis Ltd. provides laboratory-based services to pharmaceutical clients. Its services include in vitro DMPK and pharmacology. PK, bioanalysis and metabolite identification, modelling and simulation, ADME packages, due diligence, and formulation service. The company was founded by Richard Weaver in 2011 and is headquartered in Nottingham, the United Kingdom. | Health Services |
| AstraZeneca R&D Charnwood | |
UniversitätsSpital Zürich
UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services UniversitätsSpital Zürich is a renowned university hospital that specializes in university medicine, nursing, research, and teaching. UniversitätsSpital Zürich is based in Zurich, Switzerland. With over 42,000 inpatients and 600,000 outpatient consultations annually, the hospital has gained the trust of many patients. The hospital has approximately 8,500 employees and collaborates with over 40 clinics and institutes, providing patients with the expertise of its specialists and modern therapies. Gregor Zünd has been the CEO of the Swiss company since 1989. | Health Services |
